chr19-12465590-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152601.4(ZNF709):āc.332A>Gā(p.Tyr111Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,614,006 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152601.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF709 | NM_152601.4 | c.332A>G | p.Tyr111Cys | missense_variant | 4/4 | ENST00000397732.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF709 | ENST00000397732.8 | c.332A>G | p.Tyr111Cys | missense_variant | 4/4 | 1 | NM_152601.4 | P1 | |
ZNF709 | ENST00000455490.1 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152224Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 249768Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135516
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461664Hom.: 0 Cov.: 36 AF XY: 0.00000825 AC XY: 6AN XY: 727118
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152342Hom.: 1 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.332A>G (p.Y111C) alteration is located in exon 4 (coding exon 4) of the ZNF709 gene. This alteration results from a A to G substitution at nucleotide position 332, causing the tyrosine (Y) at amino acid position 111 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at